Reason: Crystallization
Distributed: U.S. Nationwide and International: Guam and Singapore.Reason: Crystallization
Distributed: U.S. Nationwide and International: Guam and Singapore.Reason: Failed Impurities/Degradation Specifications: Out of specification for unknown impurity.
Distributed: U.S. Nationwide including Puerto Rico.Reason: Failed Impurities/Degradation Specifications: out of specification results for a related compound - a degradant of fexofenadine.
Distributed: NationwideReason: Non-sterility: Product is made in a non-sterile facility and is not intended for use in humans or animals.
Distributed: United States including Puerto Rico; and CanadaReason: Failed Stability Specifications: Product is subpotent and has out of specification known and unknown impurities.
Distributed: US: Nationwide including Puerto Rico; Australia, Canada, Cyprus, Egypt, Ireland, Saudi Arabia, Qatar, Oman, Bahrain, and United Kingdom.Reason: Lack of Assurance of Sterility. A recent FDA inspection reported GMP violations potentially impacting product quality and sterility.
Distributed: NationwideReason: Failed Tablet/Capsule Specifications; recall initiated by manufacturer due to reports of wet capsules
Distributed: NationwideReason: Lack of Assurance of Sterility; increased complaints received for leaks
Distributed: Nationwide and SingaporeReason: Lack of Assurance of Sterility; increased complaints received for leaks
Distributed: Nationwide and Singapore